Mrs. Yulia Desheva, Institute of Experimental Medicine, Russia
Yulia Desheva is a researcher affiliated with St. Petersburg State University, specializing in immunology and vaccine development. She has made significant contributions to the field, particularly in the study of immune responses to viral infections and the development of probiotic-based vaccines. With a Web of Science ResearcherID of I-1493-2013 and an ORCiD of 0000-0001-9794-3520, her research is well-documented, showcasing an impressive H-index of 55. Over her career, Yulia has published 37 papers, accumulating a total of 847 citations, highlighting her impact in scientific literature. Recent publications include work on SARS-CoV-2 vaccination strategies and influenza virus immunology, reflecting her commitment to advancing public health through innovative research.
Professional Profile:
ORCID
Summary of Suitability for the Best Researcher Award: Yulia Desheva
Yulia Desheva is an exemplary candidate for the Best Researcher Award due to her significant contributions to the field of immunology and vaccine development. Affiliated with St. Petersburg State University, her research has yielded an impressive publication record, including 37 total publications with an H-index of 55, reflecting her impactful contributions and recognition by peers.
🎓 Education
- Ph.D. in Biological Sciences
St. Petersburg State University
Master’s Degree in Microbiology
Bachelor’s Degree in Biology
🔬 Research Focus
Yulia Desheva specializes in the development of oral probiotic vaccines, immunogenic responses, and antibody analysis related to viral infections such as SARS-CoV-2 and influenza. Her innovative research is crucial for understanding immune responses and improving vaccine efficacy.
🏆 Achievements
- Significant contributions to the fields of microbiology and immunology through published research.
- Engaged in high-impact studies on vaccine development and immune response analysis.
🌟 Key Areas of Interest
- Probiotic-based vaccines
- Immune response mechanisms
- Viral infections and vaccine development
- Antibody analysis in infectious diseases
Publication top Notes:
Immune response and laboratory markers in the spectrum of severity of COVID-19
Exploring Immune Response and Lab Markers Across COVID-19 Severity Levels
Evaluation of Immune Response to Mucosal Immunization with an Oral Probiotic-Based Vaccine in Mice: Potential for Prime-Boost Immunization against SARS-CoV-2
Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection